Di Leo A, Toi M, Campone M, et al. MONARCH 3: Abemaciclib as initial therapy for patients with HR+/HER2- advanced breast cancer. ESMO 2017, abstract 236O_PR.
Ook langetermijnoverleving ovariumcarcinoom hoger door HIPEC
dec 2023 | Gynaecologische oncologie